ACT

1.

$100 million grant signed for Southeast Asian malaria initiative

6 Feb 2014
Regional outreach to migrants to complement service delivery in five Southeast Asian countries

A $100-million grant to avert the spread of artemisinin resistance in five malaria endemic countries in the Greater Mekong sub-region has been signed by a full complement of stakeholders, signalling the successful achievement of a first regional application under the Global Fund’s new funding model (NFM).

5.

Global Fund Reports Sharp Drop in ACT Prices in Two AMFm Countries

25 Jul 2011

According to data compiled by the Global Fund, since the introduction of the Affordable Medicines Facility-malaria (AMFm) programme, the average cost of a course of artemisinin combination therapy (ACT) in private pharmacies has dropped by about 90% in parts of Kenya and by about 40% to 90% in Ghana, the first two countries to participate in the programme.

6.

Global Fund and Manufacturers Reduce Prices of Malaria Drugs in Eight Countries

8 Oct 2010

Malaria patients in eight countries in sub-Saharan Africa and Asia will pay significantly less for ACTs (artemisinin-based combination therapies) purchased through the private health care system, as a result of agreements between the Global Fund and six manufacturers of malaria drugs.

Subscribe to ACT